Found 5 hits for monomerid = 50245471 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Epidermal growth factor receptor
(Homo sapiens (Human)) | BDBM50245471
(4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)-N'-(...)Show SMILES Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)NNC(=O)CCN1CCOCC1 Show InChI InChI=1S/C25H28ClN7O4/c26-19-14-18(6-7-20(19)37-15-17-4-2-1-3-5-17)30-24-22(23(27)28-16-29-24)25(35)32-31-21(34)8-9-33-10-12-36-13-11-33/h1-7,14,16H,8-13,15H2,(H,31,34)(H,32,35)(H3,27,28,29,30) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | 620 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
| Assay Description Inhibition of EGFR (unknown origin) |
Bioorg Med Chem Lett 18: 4896-9 (2008)
Article DOI: 10.1016/j.bmcl.2008.07.057 BindingDB Entry DOI: 10.7270/Q2NS0TPB |
More data for this Ligand-Target Pair | |
Receptor tyrosine-protein kinase erbB-2
(Homo sapiens (Human)) | BDBM50245471
(4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)-N'-(...)Show SMILES Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)NNC(=O)CCN1CCOCC1 Show InChI InChI=1S/C25H28ClN7O4/c26-19-14-18(6-7-20(19)37-15-17-4-2-1-3-5-17)30-24-22(23(27)28-16-29-24)25(35)32-31-21(34)8-9-33-10-12-36-13-11-33/h1-7,14,16H,8-13,15H2,(H,31,34)(H,32,35)(H3,27,28,29,30) | PDB MMDB
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | 5.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
| Assay Description Inhibition of HER2 (unknown origin) |
Bioorg Med Chem Lett 18: 4896-9 (2008)
Article DOI: 10.1016/j.bmcl.2008.07.057 BindingDB Entry DOI: 10.7270/Q2NS0TPB |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50245471
(4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)-N'-(...)Show SMILES Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)NNC(=O)CCN1CCOCC1 Show InChI InChI=1S/C25H28ClN7O4/c26-19-14-18(6-7-20(19)37-15-17-4-2-1-3-5-17)30-24-22(23(27)28-16-29-24)25(35)32-31-21(34)8-9-33-10-12-36-13-11-33/h1-7,14,16H,8-13,15H2,(H,31,34)(H,32,35)(H3,27,28,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 (unknown origin) |
Bioorg Med Chem Lett 18: 4896-9 (2008)
Article DOI: 10.1016/j.bmcl.2008.07.057 BindingDB Entry DOI: 10.7270/Q2NS0TPB |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 1
(Homo sapiens (Human)) | BDBM50245471
(4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)-N'-(...)Show SMILES Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)NNC(=O)CCN1CCOCC1 Show InChI InChI=1S/C25H28ClN7O4/c26-19-14-18(6-7-20(19)37-15-17-4-2-1-3-5-17)30-24-22(23(27)28-16-29-24)25(35)32-31-21(34)8-9-33-10-12-36-13-11-33/h1-7,14,16H,8-13,15H2,(H,31,34)(H,32,35)(H3,27,28,29,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
| Assay Description Inhibition of CDK1 (unknown origin) |
Bioorg Med Chem Lett 18: 4896-9 (2008)
Article DOI: 10.1016/j.bmcl.2008.07.057 BindingDB Entry DOI: 10.7270/Q2NS0TPB |
More data for this Ligand-Target Pair | |
Aurora kinase A
(Homo sapiens (Human)) | BDBM50245471
(4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)-N'-(...)Show SMILES Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)NNC(=O)CCN1CCOCC1 Show InChI InChI=1S/C25H28ClN7O4/c26-19-14-18(6-7-20(19)37-15-17-4-2-1-3-5-17)30-24-22(23(27)28-16-29-24)25(35)32-31-21(34)8-9-33-10-12-36-13-11-33/h1-7,14,16H,8-13,15H2,(H,31,34)(H,32,35)(H3,27,28,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
| Assay Description Inhibition of Aurora A (unknown origin) |
Bioorg Med Chem Lett 18: 4896-9 (2008)
Article DOI: 10.1016/j.bmcl.2008.07.057 BindingDB Entry DOI: 10.7270/Q2NS0TPB |
More data for this Ligand-Target Pair | |